Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma.
de Claro RA, McGinn K, Kwitkowski V, Bullock J, Khandelwal A, Habtemariam B, Ouyang Y, Saber H, Lee K, Koti K, Rothmann M, Shapiro M, Borrego F, Clouse K, Chen XH, Brown J, Akinsanya L, Kane R, Kaminskas E, Farrell A, Pazdur R. de Claro RA, et al. Among authors: koti k. Clin Cancer Res. 2012 Nov 1;18(21):5845-9. doi: 10.1158/1078-0432.CCR-12-1803. Epub 2012 Sep 7. Clin Cancer Res. 2012. PMID: 22962441
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma.
Herndon TM, Deisseroth A, Kaminskas E, Kane RC, Koti KM, Rothmann MD, Habtemariam B, Bullock J, Bray JD, Hawes J, Palmby TR, Jee J, Adams W, Mahayni H, Brown J, Dorantes A, Sridhara R, Farrell AT, Pazdur R. Herndon TM, et al. Among authors: koti km. Clin Cancer Res. 2013 Sep 1;19(17):4559-63. doi: 10.1158/1078-0432.CCR-13-0755. Epub 2013 Jun 17. Clin Cancer Res. 2013. PMID: 23775332
U.S. Food and Drug Administration approval: panitumumab for epidermal growth factor receptor-expressing metastatic colorectal carcinoma with progression following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimens.
Giusti RM, Shastri K, Pilaro AM, Fuchs C, Cordoba-Rodriguez R, Koti K, Rothmann M, Men AY, Zhao H, Hughes M, Keegan P, Weiss KD, Pazdur R. Giusti RM, et al. Among authors: koti k. Clin Cancer Res. 2008 Mar 1;14(5):1296-302. doi: 10.1158/1078-0432.CCR-07-1354. Clin Cancer Res. 2008. PMID: 18316547 Clinical Trial.
Missing data in biologic oncology products.
Rothmann MD, Koti K, Lee KY, Lu HL, Shen YL. Rothmann MD, et al. Among authors: koti k. J Biopharm Stat. 2009 Nov;19(6):1074-84. doi: 10.1080/10543400903242993. J Biopharm Stat. 2009. PMID: 20183465
A Rare Case of Gastric Metastasis in Ewing's Sarcoma of the Femur.
Koti KA, Backianathan S, Sebastian P, Matthew LG, Raam M, Masih D. Koti KA, et al. Case Rep Oncol Med. 2019 May 14;2019:2870302. doi: 10.1155/2019/2870302. eCollection 2019. Case Rep Oncol Med. 2019. PMID: 31218087 Free PMC article.
Primary intracranial Parachordoma: An unusual tumor in brain.
Ghanta RK, Uppin MS, Koti K, Hui M, Uppin SG, Mukherjee KK. Ghanta RK, et al. Among authors: koti k. Surg Neurol Int. 2014 Nov 28;5(Suppl 14):S506-11. doi: 10.4103/2152-7806.145664. eCollection 2014. Surg Neurol Int. 2014. PMID: 25525557 Free PMC article.
18 results